During a live event, Ann F. Mohrbacher, MD, discussed outcomes from the latest follow-up of the ZUMA-7 and TRANSFORM trials.
Students’ access to digital devices has improved significantly as schools across the United States continue investing in technology infrastructure. A 2023 report from the National Center for Education ...
Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...
showsnob.com on MSN
Gen V season 2, episode 5 recap: Cipher is working with one of The Seven
We learn a little more about Cipher in Gen V season 2, episode 5, but it's not enough to figure him out. Take a look at the ...
Across the United States, more schools are implementing policies restricting cell phones as concerns about digital ...
But Why Tho? on MSN
RECAP: ‘Gen V’ Season 2 Episode 5 — “The Kids Are Not All Right”
Gen V Season 2 Episode 5 gets the momentum back after a brief slow-down, showing why the show is so compelling. The post ...
CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.
Brian Tait, chief scientific officer, Haplomic Technologies Pty Ltd, explores the clinical benefits of haplotyping in single-chromosome sequencing and unrelated donor bone marrow transplantation (HSCT ...
Google has been ordered to pay $425 million in a privacy-related class action lawsuit. You may be due some money, but the ...
Regeneron Pharmaceuticals is seeing revenue growth in key products that is now offsetting declining revenue in its previous ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback